Signal transduction inhibitors in treatment of myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are a group of hematologic disorders characterized by ineffective hematopoiesis that results in reduced blood counts. Although MDS can transform into leukemia, most of the morbidity experienced by these patients is due to chronically low blood counts. Conventional cyt...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bachegowda, Lohith, Gligich, Oleg, Mantzaris, Ionnis, Schinke, Carolina, Wyville, Dale, Carrillo, Tatiana, Braunschweig, Ira, Steidl, Ulrich, Verma, Amit
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3716523/
https://ncbi.nlm.nih.gov/pubmed/23841999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-50
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi